Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum nuclear membrane refers to the double-membraned envelope surrounding the nucleus of the malaria parasite Plasmodium falciparum. It forms a selective barrier, separating nuclear and cytoplasmic contents, and is fundamental for cellular processes including nuclear-cytoplasmic transport, mitosis (which occurs without nuclear envelope breakdown in this species - "closed mitosis"), and organization of nuclear pore complexes (NPCs)[2][3]. The nuclear membrane plays a crucial role in schizogony, the parasite’s form of cell division, by providing a platform for key protein complexes such as the LINC complex, which links nuclear and cytoskeletal dynamics and is essential for parasite proliferation during infection[4][5]. The composition and dynamics of the nuclear membrane are distinct from human cells, with variations in associated proteins (e.g., SUN-domain proteins and nucleoporins such as Nup313, Nup221, Nup138, and Sec13)[2][4][9]. While it is foundational for parasite biology, the nuclear membrane itself is not classified as a canonical molecular target like receptors, enzymes, or channels[2][4][9].\n\nKey clarification: This target is scientifically incorrect for purposes such as drug development databases, as it is a structure, not a drug-targetable molecule or receptor. Canonical therapeutic targets instead focus on specific nuclear membrane-associated proteins (e.g., SUN-domain proteins, nucleoporins, nuclear transporters), some of which are essential for parasite viability and could be targets for antimalarial research[4][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum nuclear membrane.